Datopotamab deruxtecan (ADC)
Datopotamab deruxtecan is an ADC consisting of a TROP2-directed antibody and Dxd, a topoisomerase I inhibitor, used for the study of breast cancer.
Product Specifications
Product Name Alternative
DS-1062a
Reactivity
Human
Applications
Research Grade Biosimilar
Stability
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.
Endotoxin
Please contact with the lab for this information.
Purity
>90% as determined by SEC.
Form
Liquid
Notes
For research use only. Not suitable for clinical or therapeutic use.
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP56158_P050-FITC 100 µL
Ppp2r2a Antibody - C-terminal region : FITC (ARP56158_P050-FITC)
Sign In for Pricing
View Details 
SR307588 1 Kit
DATF1 (DIDO1) Human siRNA Oligo Duplex (Locus ID 11083)
Sign In for Pricing
View Details 